News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,857 Results
Type
Article (39618)
Company Profile (247)
Press Release (653992)
Section
Business (204259)
Career Advice (2012)
Deals (35484)
Drug Delivery (93)
Drug Development (80970)
Employer Resources (170)
FDA (16153)
Job Trends (14871)
News (345303)
Policy (32530)
Tag
Academia (2537)
Alliances (49384)
Alzheimer's disease (1314)
Approvals (16137)
Artificial intelligence (200)
Bankruptcy (357)
Best Places to Work (11649)
Biotechnology (175)
Breast cancer (225)
Cancer (1710)
Cardiovascular disease (128)
Career advice (1675)
CAR-T (121)
Cell therapy (354)
Clinical research (65267)
Collaboration (661)
Compensation (370)
COVID-19 (2565)
C-suite (160)
Data (1629)
Diabetes (211)
Diagnostics (6297)
Earnings (85461)
Employer resources (147)
Events (111309)
Executive appointments (565)
FDA (17055)
Funding (605)
Gene therapy (245)
GLP-1 (648)
Government (4363)
Healthcare (18801)
Infectious disease (2676)
Inflammatory bowel disease (121)
Interviews (310)
IPO (16492)
Job creations (3660)
Job search strategy (1426)
Layoffs (438)
Legal (7906)
Lung cancer (255)
Manufacturing (236)
Medical device (13340)
Medtech (13345)
Mergers & acquisitions (19369)
Metabolic disorders (548)
Neuroscience (1715)
NextGen: Class of 2025 (6528)
Non-profit (4478)
Northern California (2091)
Obesity (306)
Opinion (194)
Patents (162)
People (56917)
Phase I (20328)
Phase II (28753)
Phase III (21400)
Pipeline (711)
Postmarket research (2562)
Preclinical (8578)
Radiopharmaceuticals (241)
Rare diseases (321)
Real estate (5916)
Regulatory (21950)
Research institute (2312)
Resumes & cover letters (350)
Southern California (1793)
Startups (3577)
United States (18456)
Vaccines (611)
Weight loss (208)
Date
Last 7 days (594)
Last 30 days (2427)
Last 365 days (34430)
2025 (4437)
2024 (35264)
2023 (40143)
2022 (51227)
2021 (55780)
2020 (54152)
2019 (46628)
2018 (35095)
2017 (32224)
2016 (31610)
2015 (37664)
2014 (31411)
2013 (26416)
2012 (28636)
2011 (29315)
2010 (27363)
Location
Africa (721)
Arizona (211)
Asia (37732)
Australia (6155)
California (4765)
Canada (1715)
China (392)
Colorado (217)
Connecticut (230)
Europe (80805)
Florida (688)
Georgia (165)
Illinois (455)
Indiana (259)
Maryland (741)
Massachusetts (3606)
Michigan (199)
Minnesota (336)
New Jersey (1349)
New York (1359)
North Carolina (834)
Northern California (2091)
Ohio (174)
Pennsylvania (1098)
South America (1097)
Southern California (1793)
Texas (702)
Utah (143)
Washington State (468)
693,857 Results for "venus medtech hangzhou inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.
Venus Medtech, a leading provider of integrated solutions for transcatheter structural heart valvular therapies in China, announced that its in-house developed innovative transcatheter pulmonic valve replacement system, VenusP-Valve, has completed its first implantation in the PROTEUS IDE Pivotal Clinical Study at the University of Virginia School of Medicine.
June 14, 2024
·
4 min read
Press Releases
Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study
September 5, 2024
·
5 min read
Venus Medtech VenusP-Valve transcatheter pulmonic valve replacement system granted Health Canada approval
Venus Medtech (02500. HK) announced today that, VenusP-Valve, the company’s in-house developed innovative transcatheter pulmonic valve replacement (TPVR) system, cleared approval from Health Canada.
February 5, 2024
·
4 min read
Venus Concept Inc. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13th
Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO) today announced that management will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which is being held at the Cliff Lodge in Snowbird, UT from February 13th – 14th.
February 6, 2024
·
1 min read
Press Releases
Sanara MedTech Inc. Expands Executive Leadership Team with New Appointments
January 22, 2025
·
6 min read
Press Releases
Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024
January 22, 2025
·
7 min read
Biotech Bay
Penumbra, Inc. to Present at the Truist Securities MedTech Conference 2024
Penumbra, Inc. announced that its management team is scheduled to present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024.
June 4, 2024
·
1 min read
Press Releases
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.
January 24, 2025
·
5 min read
Business
Product Creation Studio Partners With PatchClamp Medtech Inc. to Develop Revolutionary Dural Repair System
Product Creation Studio, a premier provider of engineering and design services, is excited to announce a new partnership with PatchClamp Medtech Inc.
June 24, 2024
·
3 min read
Business
Sanara MedTech Inc. Announces First Quarter 2024 Results
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI) announced today its strategic, operational and financial results for the quarter ended March 31, 2024.
May 13, 2024
·
15 min read
1 of 69,386
Next
